Top Stories
US : FDA approves a third new weight-loss pill
The US Food and Drug Administration (FDA) has approved the combination of bupropion/naltrexone, developed by Orexigen Therapeutics, to be known as Contrave, for the treatment of obesity. Contrave's maker had hoped for approval three years ago, but ...
Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS